Aorticlab SRL
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 13, 2026The maintenance fee for Transcatheter Device for the Treatment of Calcified Heart Valve Leaflets (US 11,672,552) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
- 1 fee due Aug 25, 2027The maintenance fee for Device for transcatheter insertion into the aortic root at the sinotubular junction (US 10,568,729) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,568,729 | Device for transcatheter insertion into the aortic root at the sinotubular junction In force · From the USPTO record | In force | From the USPTO record | |
| US 10,213,227 | Transcatheter Device for the Ablation of Calcified Tissue at the Flaps of an Aortic Valve In force · High confidence | In force | High confidence | |
| US 11,559,396 | Transcatheter valve prosthesis for blood vessel In force · From the USPTO record | In force | From the USPTO record | |
| US 11,672,552 | Transcatheter Device for the Treatment of Calcified Heart Valve Leaflets In force · High confidence | In force | High confidence | |
| US 12,096,949 | Device for the treatment of tissue calcification In force · From the USPTO record | In force | From the USPTO record | |
| US 12,465,477 | Transcatheter anti embolic filter for arterial and venous vessels In force · From the USPTO record | In force | From the USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.